An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The development of treatments for alcohol dependence has been significantly complicated by the multiple actions of ethanol at the neurotransmitter level, heterogeneity among patients with alcohol dependence, the complexity of defining and measuring the phenomenon of craving, and the challenge of quantifying alcohol intake in patients. Increasingly, anticonvulsant medications are showing promise for the safe and effective amelioration of alcohol withdrawal symptoms. Furthermore, there is evidence that anticonvulsant medications are promising treatments for reducing drinking and preventing relapse among alcohol-dependent individuals. In recent years, many medications have been evaluated for the treatment of alcohol dependence, including those that interact with dopaminergic, serotonergic, opioid or glutamate and/or GABA systems. So far, naltrexone, acamprosate and, more recently, the anticonvulsant, topiramate, have shown some efficacy for the treatment of heterogeneous populations of individuals with alcohol dependence. Both ondansetron and sertraline appear to have some efficacy in treating different subgroups of alcoholic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070 · cited 1×
“The VTA sends dopaminergic efferents to the nucleus accumbens, which connects to the amygdala and the dorsolateral prefrontal area of the cortex [3,4].”
BackgroundNaltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Self-citationNaltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618
Cited by
The genetics of addictions: uncovering the genes
Goldman, D., Oroszi, G., & Ducci, F. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1635 · Cited by 1,099
Neuropharmacology of alcohol addiction
Vengeliene, V, Bilbao, A., Molander, A., & Spanagel, R. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.30 · Cited by 571
Acamprosate Efficacy in Alcohol‐Dependent Patients: Summary of Results from Three Pivotal Trials
Kranzler, H. R., & Gage, A. (2008) · The American Journal on Addictions · doi:10.1080/10550490701756120 · Cited by 212
Ciccocioppo, R., Economidou, D., Cippitelli, A., Cucculelli, M., Ubaldi, M., Soverchia, L., Lourdusamy, A., & Massi, M. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00032.x · Cited by 166
“For example, the anti-epileptic drug topiramate, the selective 5-HT3 receptor antagonist ondansetron, seems to be particularly promising (Johnson 2004; Williams 2005).”
BackgroundSwann, A. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05146.x · Cited by 109
Metadata
- Authors
- Johnson, B. A.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa UK Limited
- Published
- 2004-09
- Volume
- 5
- Issue
- 9
- Pages
- 1943-1955
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W2121951622
- Cited by
- 38
- References
- 4
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence. https://app.cochat.ai/papers/10.1517/14656566.5.9.1943
- The paper
- Johnson, B. A. (2004). An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence. Expert Opinion on Pharmacotherapy. https://doi.org/10.1517/14656566.5.9.1943
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.